June 26 (SeeNews) - Bulgaria's Tchaikapharma High Quality Medicines said on Thursday that its shareholders approved a proposal to reinvest part of the 2024 net profit in a capital increase of 4.1 million levs ($2.4 million/2.1 million euro) via a new share issue.